Webb, Muriel

A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease

Zelber–Sagi, S., Kessler, A., Brazowsky, E., Webb, M., Lurie, Y., Santo, M., Leshno, M., Blendis, L., Halpern, Z., & Oren, R. (2006) · Clinical Gastroenterology and Hepatology

Liver Disease Diagnosis and TreatmentPharmacology and Obesity Treatment

Cited by 317

High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance

Zelber-Sagi, S., Ivancovsky-Wajcman, D., Fliss Isakov, N., Webb, M., Orenstein, D., Shibolet, O., & Kariv, R. (2018) · Journal of Hepatology

Nutritional Studies and DietLiver Disease Diagnosis and Treatment

Cited by 297

Role of leisure-time physical activity in nonalcoholic fatty liver disease: A population-based study

Zelber-Sagi, S., Nitzan-Kaluski, D., Goldsmith, R., Webb, M., Zvibel, I., Goldiner, I., Blendis, L., Halpern, Z., & Oren, R. (2008) · Hepatology

Liver Disease Diagnosis and TreatmentPhysical Activity and Health

Cited by 296

Prospective Longitudinal Trends in Body Composition and Clinical Outcomes 3 Years Following Sleeve Gastrectomy

Sherf-Dagan, S., Zelber-Sagi, S., Buch, A., Bar, N., Webb, M., Sakran, N., Raziel, A., Goitein, D., Keidar, A., & Shibolet, O. (2019) · Obesity Surgery

Bariatric Surgery and OutcomesBody Contouring and Surgery

Cited by 26